WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001005802) ANTISENSE MODULATION OF FADD EXPRESSION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/005802    International Application No.:    PCT/US1999/030653
Publication Date: 25.01.2001 International Filing Date: 23.12.1999
Chapter 2 Demand Filed:    12.02.2001    
IPC:
A61K 38/00 (2006.01), C12N 15/11 (2006.01)
Applicants: ISIS PHARMACEUTICALS, INC. [US/US]; 2292 Faraday Avenue Carlsbad, CA 92008 (US) (For All Designated States Except US).
MONIA, Brett, P. [US/US]; (US) (For US Only).
BAKER, Brenda, F. [US/US]; (US) (For US Only).
ZHANG, Hong [US/US]; (US) (For US Only).
COWSERT, Lex, M. [US/US]; (US) (For US Only)
Inventors: MONIA, Brett, P.; (US).
BAKER, Brenda, F.; (US).
ZHANG, Hong; (US).
COWSERT, Lex, M.; (US)
Agent: LICATA, Jane, Massey; Law Offices of Jane Massey Licata 66 E. Main Street Marlton, NJ 08053 (US)
Priority Data:
09/357,072 19.07.1999 US
Title (EN) ANTISENSE MODULATION OF FADD EXPRESSION
(FR) MODULATION ANTI-SENS DE L'EXPRESSION DU DOMAINE FADD
Abstract: front page image
(EN)Antisense compounds, compositions and methods are provided for modulating the expression of FADD. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding FADD. Methods of using these compounds for modulation of FADD expression and for treatment of diseases associated with expression of FADD are provided.
(FR)Cette invention se rapporte à des composés anti-sens, à des compositions et à des procédés servant à moduler l'expression du domaine FADD. Ces compositions comprennent des composés anti-sens, notamment des oligonucléotides anti-sens, ciblés sur des acides nucléiques codant le domaine FADD. Des procédés d'utilisation de ces composés pour moduler l'expression du domaine FADD et pour traiter les maladies associées à l'expression du domaine FADD sont également décrits.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)